Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-04-06 2:08 pm Sale | 13D | RA PHARMACEUTICALS INC RARX | NEW ENTERPRISE ASSOCIATES 13 LP | 0 0% | -6,135,234 (Position Closed) | View |
| 2020-02-10 07:32 am Purchase | 13G | RA PHARMACEUTICALS INC RARX | BlackRock Inc. BLK | 4,488,324 9.5% | 1,843,063 (+69.67%) | View |
| 2019-11-08 09:04 am Sale | 13G | RA PHARMACEUTICALS INC RARX | WELLINGTON MANAGEMENT GROUP LLP | 179,804 0.38% | -5,078,148 (-96.58%) | View |
| 2019-10-17 2:11 pm Unchanged | 13D | RA PHARMACEUTICALS INC RARX | NEW ENTERPRISE ASSOCIATES 13 LP | 6,135,234 13% | 0 (Unchanged) | View |
| 2019-10-11 4:12 pm Purchase | 13D | RA PHARMACEUTICALS INC RARX | RA CAPITAL MANAGEMENT L.P. | 4,858,260 10.3% | 1,006,452 (+26.13%) | View |